User blogs
Market Research Future (MRFR) has published
a research report about the global neurovascular
devices market trends to touch over USD 4.2 Billion by 2030. MRFR also
anticipates the global market’s growth to be at a rate of 5.7% during the
review period 2022 to 2030. This report talks about the market scenario and
future prospects regarding growth. In this report, the global neurovascular
devices market has been segmented on the basis of end-user, product,
therapeutic application, and lastly region.
Problems related to the nervous system are
serious. They cannot be seen easily, and their therapies usually lie in
surgeries where patients and doctors need to decide which surgeries are more
invasive and which are less invasive. Neurovascular devices are necessary for
treating neurovascular diseases. These devices have been developed due to
demand for minimally invasive procedures. There has never been a dearth of
neurovascular patients. Therefore, the global neurovascular devices market has
huge scope for growth. Factors contributing to the growth of this market
include favorable reimbursement policies, and ongoing product development &
commercialization.
On the basis of the end-users, this market
has been segmented into ambulatory surgical units and hospitals & clinics.
Ambulatory surgical units work for ambulatory surgery centers (ASC) that are
also known as outpatient surgery centers, same-day surgery centers, or
surgicenters. Ambulatory surgical units perform surgical procedures not
requiring an overnight hospital stay. Such surgery is commonly less complicated
than those required hospitalization.
Key Players
The key players in the global neurovascular
devices market include Abbott Laboratories (USA), Blockade Medical LLC.
(France), Delaware Corporation (USA), Evasc (Canada), Gynesonics (USA),
Johnson & Johnson Services, Inc. (the USA), Medikit Co., Ltd. (Japan),
Medtronic (USA), Merit Medical Systems Inc. (USA), MicroPort Scientific
Corporation (China), Neuravi (Israel), OxfordEndovascular (UK), Penumbra, Inc.
(USA), Rapid Medical (Israel), Sensome (France), Secant Group LLC (USA),
Stryker (USA), Terumo Corporation (Japan), and W. L. Gore & Associates,
Inc. (USA).
Segmentation:
The product-based segmentation segments the
market into aneurysm coiling & embolization devices, cerebral balloon
angioplasty & stenting systems, neurovascular
catheters, neuro thrombectomy devices, and a support device. The aneurysm
coiling & embolization devices segment has been sub-segmented into embolic
coils, flow diversion devices, and liquid embolic. Embolic coils block blood
flow into an aneurysm (weak area of an artery). The embolic protection systems
have been segmented into balloon occlusion devices and distal filter devices.
Cerebral angioplasty is a procedure useful for opening the partially blocked
carotid and vertebral arteries in the neck. They can also do the same for blood
vessels within the brain. It has been segmented into is sub-segmented into
carotid artery stents and embolic protection systems. Stenting system indicates
an improvement of coronary luminal diameter in patients with symptomatic
ischemic heart disease. Neurothrombectomy devices are used for treating acute
ischemic strokes. They have been sub-segmented into aspiration devices,
retrieval systems, and suction devices. Based on therapeutic application, the
market has been segmented into the hemorrhagic stroke and ischemic strokes. A
hemorrhagic stroke can be defined as either a brain aneurysm burst or a
weakened blood vessel leak. The different types of ischemic strokes occur when
the body is deprived of oxygen or any other important nutrients.
The regional segmentation of the global neurovascular
devices market Report comprises of The Americas (North America & South
America), Europe, Asia Pacific, and Middle East & Africa (MEA) region. The
Americas dominate the global neurovascular devices market due to a large number
of patients suffering from neurovascular diseases like arteriovenous
malformations (AVMs) and brain aneurysm. Due to technological advancement, high
disposable income, and the availability of better medical facilities, North
America is the bigger market than South America. Moreover, increasing healthcare
expenditure, government aid to researches in the field of medical sciences and
the presence of the key players in North America boosts the growth of the
market in North America. Majority key players in this region are based in the
United States of America (USA).
The Asia Pacific region is the fastest
growing market for the market due to continuously developing economies like
China and India, increasing demands for minimally invasive surgeries by the
growing geriatric population, and the presence of a huge patient population.
Asia Pacific region is yet to achieve the infrastructure development and
technological advancement as par the level of North America and Europe, and
there are few countries in this region that are technologically advanced. In
the Asia Pacific region, the biggest markets are Australia, China, India,
Japan, and South Korea, followed by the rest of Asia Pacific. MEA region is a
small market due to political instability in most countries due to movements
like Arab Spring. Lack of technology and less investment in healthcare due to
healthcare not being considered a priority by governments in this region are
the reasons for a small market. The biggest markets in this region are Kuwait,
Oman, Saudi Arabia, Qatar, and United Arab Emirates (UAE), followed by rest of
MEA region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (MRFR) has published
a research report about the global neurovascular
devices market size to touch over USD 4.2 Billion by 2030. MRFR also
anticipates the global market’s growth to be at a rate of 5.7% during the
review period 2022 to 2030. This report talks about the market scenario and
future prospects regarding growth. In this report, the global neurovascular
devices market has been segmented on the basis of end-user, product,
therapeutic application, and lastly region.
Problems related to the nervous system are
serious. They cannot be seen easily, and their therapies usually lie in
surgeries where patients and doctors need to decide which surgeries are more
invasive and which are less invasive. Neurovascular devices are necessary for
treating neurovascular diseases. These devices have been developed due to
demand for minimally invasive procedures. There has never been a dearth of
neurovascular patients. Therefore, the global neurovascular devices market has
huge scope for growth. Factors contributing to the growth of this market
include favorable reimbursement policies, and ongoing product development &
commercialization.
On the basis of the end-users, this market
has been segmented into ambulatory surgical units and hospitals & clinics.
Ambulatory surgical units work for ambulatory surgery centers (ASC) that are
also known as outpatient surgery centers, same-day surgery centers, or
surgicenters. Ambulatory surgical units perform surgical procedures not
requiring an overnight hospital stay. Such surgery is commonly less complicated
than those required hospitalization.
Key Players
The key players in the global neurovascular
devices market include Abbott Laboratories (USA), Blockade Medical LLC.
(France), Delaware Corporation (USA), Evasc (Canada), Gynesonics (USA),
Johnson & Johnson Services, Inc. (the USA), Medikit Co., Ltd. (Japan),
Medtronic (USA), Merit Medical Systems Inc. (USA), MicroPort Scientific
Corporation (China), Neuravi (Israel), OxfordEndovascular (UK), Penumbra, Inc.
(USA), Rapid Medical (Israel), Sensome (France), Secant Group LLC (USA),
Stryker (USA), Terumo Corporation (Japan), and W. L. Gore & Associates,
Inc. (USA).
Segmentation:
The product-based segmentation segments the
Neurovascular
Devicesmarket insights into aneurysm coiling & embolization
devices, cerebral balloon angioplasty & stenting systems, neurovascular catheters, neuro thrombectomy devices,
and a support device. The aneurysm coiling & embolization devices segment
has been sub-segmented into embolic coils, flow diversion devices, and liquid
embolic. Embolic coils block blood flow into an aneurysm (weak area of an
artery). The embolic protection systems have been segmented into balloon
occlusion devices and distal filter devices. Cerebral angioplasty is a
procedure useful for opening the partially blocked carotid and vertebral
arteries in the neck. They can also do the same for blood vessels within the
brain. It has been segmented into is sub-segmented into carotid artery stents
and embolic protection systems. Stenting system indicates an improvement of
coronary luminal diameter in patients with symptomatic ischemic heart disease.
Neurothrombectomy devices are used for treating acute ischemic strokes. They
have been sub-segmented into aspiration devices, retrieval systems, and suction
devices. Based on therapeutic application, the market has been segmented into
the hemorrhagic stroke and ischemic strokes. A hemorrhagic stroke can be
defined as either a brain aneurysm burst or a weakened blood vessel leak. The
different types of ischemic strokes occur when the body is deprived of oxygen
or any other important nutrients.
The regional segmentation of the global
neurovascular devices market comprises of The Americas (North America &
South America), Europe, Asia Pacific, and Middle East & Africa (MEA)
region. The Americas dominate the global neurovascular devices market due to a
large number of patients suffering from neurovascular diseases like
arteriovenous malformations (AVMs) and brain aneurysm. Due to technological
advancement, high disposable income, and the availability of better medical
facilities, North America is the bigger market than South America. Moreover,
increasing healthcare expenditure, government aid to researches in the field of
medical sciences and the presence of the key players in North America boosts
the growth of the market in North America. Majority key players in this region
are based in the United States of America (USA).
Europe holds the second largest share in
global neurovascular devices market. Increasing prevalence of the neurovascular
diseases and the presence of a well-developed healthcare sector are the major
factors that drive the market growth in this region. Due to reasons same as The
Americas, Western Europe market is bigger than Eastern Europe. In Europe, most
of the key players in this market are based in France and the United Kingdom
(UK).
The Asia Pacific region is the fastest
growing market for the market due to continuously developing economies like
China and India, increasing demands for minimally invasive surgeries by the
growing geriatric population, and the presence of a huge patient population.
Asia Pacific region is yet to achieve the infrastructure development and
technological advancement as par the level of North America and Europe, and
there are few countries in this region that are technologically advanced. In
the Asia Pacific region, the biggest markets are Australia, China, India,
Japan, and South Korea, followed by the rest of Asia Pacific. MEA region is a
small market due to political instability in most countries due to movements
like Arab Spring. Lack of technology and less investment in healthcare due to
healthcare not being considered a priority by governments in this region are
the reasons for a small market. The biggest markets in this region are Kuwait,
Oman, Saudi Arabia, Qatar, and United Arab Emirates (UAE), followed by rest of
MEA region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Neurosurgeons and clinical experts are increasingly looking into restorative options that can significantly lower the risk of casualty or seriousness of neurovascular illnesses in patients.
Neurovascular Devices Market was valued at US$ 2.5 Bn. in 2021. The Global Neurovascular Devices Market size is estimated to grow at a CAGR of 6 % over the forecast period.
Request for free sample:
https://www.maximizemarketresearch.com/request-sample/31229
Market Scope:
The Neurovascular Devices market research from Maximize Market Research provides broad market insights for manufacturers, suppliers, distributors, and investors. All stakeholders in the Neurovascular Devices market, including industry experts, researchers, journalists, and business researchers, can benefit from the information and statistics provided in this report.
Maximize Market Research report explains how to do in-depth research on the neurovascular medical device companies and develop conclusions about the market's future growth factors. The research technique combines primary and secondary research methodologies to ensure the authenticity and validity of the findings in this study.
Neurovascular Devices Market Overview:
The report contains an in-depth analysis, revenue statistics, and other essential data about the Neurovascular Devices Market industry, as well as various trends, drivers, limitations, opportunities, and threats that the market will face throughout the forecast period. The research looks at the financials, supply chain trends, technological advancements, and important advances of the industry's many leading competitors, as well as future strategies, acquisitions & mergers, and market footprint.
Request Sample Pages:
https://www.maximizemarketresearch.com/request-sample/31229
Segmentation:
The cerebral aneurysm segment is estimated to account for the largest share of the global interventional neurology market, by pathology, in 2021, driven by the developing reception of negligibly obtrusive neurosurgical techniques among neurosurgeons, expanding medical care consumption in arising nations, and expanding frequency of hazard factors, (for example, hypertension, cigarette smoking, elevated cholesterol, diabetes, and weight).
Key Players:
• Medtronic
• Johnson and Johnson Services Inc.
• Penumbra, Inc.
• Microport Scientific Corporation
• Stryker
• Microvention Inc (Terumo Corporation)
• Codman Neuro (Integra Lifesciences)
Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price, and Gross Margin & Sales by Product are all included in this Neurovascular Devices market research report.
Download Free Sample Report:
https://www.maximizemarketresearch.com/request-sample/31229
Regional Analysis:
The Neurovascular Devices market research has been divided into various important regions, as follows:
- Asia-Pacific region (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
- European Union (Turkey, Germany, Russia UK, Italy, France, etc.)
- The continent of North America (the United States, Mexico, and Canada.)
- South America is a continent in South America (Brazil etc.)
- The continents of Africa and the Middle East (GCC Countries and Egypt.)
The research offers market size, growth rate, and country-level data, as well as demand and supply aspects that influence worldwide Neurovascular Devices market growth in different nations.
Impact of COVID-19 on the Neurovascular Devices Market:
In the Neurovascular Devices market research, the impact of COVID-19 on the market is thoroughly studied. Researchers at Maximize Market Research, who are tracking the situation throughout the world as a result of the COVID-19 dilemma, feel that the market will give profitable prospects for producers. The goal of the paper is to give a more complete picture of the current situation, the economic slump, and COVID-19's impact on the entire business.
Key Questions Answered in the Neurovascular Devices Market Report are:
- How much does Neurovascular Devices market sell for, how much does it produce, how much it consumes, how much it imports, and how much it exports?
- Who are the leading participants in the Neurovascular Devices Market on a global scale? What is the current state of their business (capacity, production, sales, pricing, cost, gross profit, and revenue)?
- What are the market opportunities and dangers for Neurovascular Devices providers in the Neurovascular Devices industry?
- Which application, end-user, or product category could benefit from new growth opportunities?
About Us:
Maximize Market Research provides B2B and B2C research on 12000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defence and other manufacturing sectors.
Contact Us:
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT Park Phase 2,
Pune Bangalore Highway,
Narhe, Pune, Maharashtra 411041, India.
Email:sales@maximizemarketresearch.com
Phone No.: +91 20 6630 3320
Website:www.maximizemarketresearch.com
Similar Reports:
https://blog.naver.com/maximizegeeta/223004133717
Key Players in the global neurovascular devices market include Abbott Laboratories (USA), Blockade Medical LLC. (France), Delaware Corporation (USA), Evasc (Canada), Gynesonics (USA), Johnson & Johnson Services, Inc. (the USA), Medikit Co., Ltd. (Japan), Medtronic (USA), Merit Medical Systems Inc. (USA), MicroPort Scientific Corporation (China), Neuravi (Israel), OxfordEndovascular (UK), Penumbra, Inc. (USA), Rapid Medical (Israel), Sensome (France), Secant Group LLC (USA), Stryker (USA), Terumo Corporation (Japan), and W. L. Gore & Associates, Inc. (USA).
Problems related to the nervous system are serious. They cannot be seen easily, and their therapies usually lie in surgeries where patients and doctors need to decide which surgeries are more invasive and which are less invasive. Neurovascular devices are necessary for treating neurovascular diseases. These devices have been developed due to demand for minimally invasive procedures. There has never been a dearth of neurovascular patients. Therefore, the global neurovascular devices market has huge scope for growth. Factors contributing to the growth of this market include favorable reimbursement policies, and ongoing product development & commercialization.
Market Research Future (MRFR) has published a research report about the global neurovascular devices market that predicts the growth of this market between 2017 and 2023, with 8.8% CAGR. This report talks about the market scenario and future prospects regarding growth. In this report, the global neurovascular devices market has been segmented on the basis of end-user, product, therapeutic application, and lastly region.
On the basis of the end-users, this market has been segmented into ambulatory surgical units and hospitals & clinics. Ambulatory surgical units work for ambulatory surgery centers (ASC) that are also known as outpatient surgery centers, same-day surgery centers, or surgicenters. Ambulatory surgical units perform surgical procedures not requiring an overnight hospital stay. Such surgery is commonly less complicated than those required hospitalization.
Segmentation:
The product-based segmentation segments the market into aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, neurovascular catheters, neuro thrombectomy devices, and a support device. The aneurysm coiling & embolization devices segment has been sub-segmented into embolic coils, flow diversion devices, and liquid embolic. Embolic coils block blood flow into an aneurysm (weak area of an artery). The embolic protection systems have been segmented into balloon occlusion devices and distal filter devices. Cerebral angioplasty is a procedure useful for opening the partially blocked carotid and vertebral arteries in the neck. They can also do the same for blood vessels within the brain. It has been segmented into is sub-segmented into carotid artery stents and embolic protection systems. Stenting system indicates an improvement of coronary luminal diameter in patients with symptomatic ischemic heart disease. Neurothrombectomy devices are used for treating acute ischemic strokes. They have been sub-segmented into aspiration devices, retrieval systems, and suction devices. Based on therapeutic application, the market has been segmented into the hemorrhagic stroke and ischemic strokes. A hemorrhagic stroke can be defined as either a brain aneurysm burst or a weakened blood vessel leak. The different types of ischemic strokes occur when the body is deprived of oxygen or any other important nutrients.
The regional segmentation of the global neurovascular devices market comprises of The Americas (North America & South America), Europe, Asia Pacific, and Middle East & Africa (MEA) region. The Americas dominate the global neurovascular devices market due to a large number of patients suffering from neurovascular diseases like arteriovenous malformations (AVMs) and brain aneurysm. Due to technological advancement, high disposable income, and the availability of better medical facilities, North America is the bigger market than South America. Moreover, increasing healthcare expenditure, government aid to researches in the field of medical sciences and the presence of the key players in North America boosts the growth of the market in North America. Majority key players in this region are based in the United States of America (USA).
Europe holds the second largest share in global neurovascular devices market. Increasing prevalence of the neurovascular diseases and the presence of a well-developed healthcare sector are the major factors that drive the market growth in this region. Due to reasons same as The Americas, Western Europe market is bigger than Eastern Europe. In Europe, most of the key players in this market are based in France and the United Kingdom (UK).
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
